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OBJECTIVES Syringa pinnatifolia var. alashanensis (SP) is a tradi-
tional Mongolian medicine. It is widely used for the treatment of
cardiovascular disorders. However, the pharmacological mechanisms
are still unclear. Our purpose is to investigate the underlying mech-
anism of the anti-myocardial ischemia effect of ethanol extracts of SP
stems.
METHODS The stems of Syringa pinnatifolia var. alashanensis was
extracted with 95% ethanol. Model of male C57 mice with left anterior
descending (LAD) artery ligated were used to evaluate the anti-
myocardial ischemia effect. They were divided into four groups
(n¼10) randomly by weight as follows: sham group, model group, SP
group, and the positive group (aspirin). Echocardiography was per-
formed to determine heart function by EF and FS. CK-MB and LDH
in serum, TXB2 and 6-keto-PGF1a in both of plasma and protein
homogenate of myocardial tissue were detected. Levels of cyclo-
oxygenase (COX)-1 and COX-2 in heart tissue were tested by
western blot. Besides, frozen sections were also used to verify the
mechanism.
RESULTS The extracts of SP can signiﬁcant improve EF (p<0.01) and
FS (p<0.01) compared with model group. CK-MB and LDH in SP group
were both decreased obviously (p<0.01), approaching to the sham
group. Besides, the extract can also upregulate 6-keto-PGF1a and
decrease TXB2 in plasma of mice, while in the protein homogenate of
the infarction area edge in myocardial tissues levels of the factors are
exactly opposite, suggesting that SP extract keeps 6-keto-PGF1a and
TXB2 (p<0.01) balanced compared with the model group, which are
closer to the sham group compared with aspirin group (P>0.05).
Moreover, SP showed an obvious effect on reducing inﬂammatory
cells, which inﬁltrated in the infarct myocardial tissue. The thera-
peutic effect of SP is associated with down-regulated expression of
COX-1 (p<0.01) and COX-2 (p<0.01).
CONCLUSIONS These results suggest that the ethanol extracts of SP
possessing protective effect of anti-myocardial ischemia activity and
better than aspirin, via down-regulating the expression of COX-1 and
COX-2, and adjusting the imbalance between TXB2 and 6-keto-PGF1a
to the normal. This work provided evidence for traditional use of
Mongolian medicine and have enormous potential for coronary heart
disease (CHD)-clinical application.
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OBJECTIVES To investigate the effects of Ginsenoside Rb1 on
Homocysteine(HCY)-induced endothelial dysfunction and inﬂamma-
tory response.
METHODS With the informed consents of puerperants, the normal
fetal umbilical cords were obtained through uterine-incision delivery
in Third Afﬁliated Hospital, Sun Yat-sun University. HUVECs were
isolated by Percoll density gradient centrifugation from fetal umbilical
cords with digestion of collagenase typeIperfusion, and then sus-
pended in Medium 199 cultured in 0.05 volume fraction of CO2
incubator at 37C. After the HUVECs were identiﬁed by ﬂow cytometry
with the cell marker CD31, The second or third passage was used for
study. MTT assay was used to detect cell viability: HUVECs during the
logarithmic phase were inoculated in 96-well plates with Medium 199
in 0.05 volume fraction of CO2 incubator at 37C for 48h, at 80%
conﬂuence, incubated in serum-free medium, and divided into two
groups, each group including eight parallel wells, blank control group
was untreated, the latter cultured and added with HCY of the con-
centrations of 0.1, 0.25, 0.5, and 1.0 mmol/L respectively, or HCY
0.5mmol/LþRb1 of the concentrations of 10, 20, 40, and 60mmol/L.After the cells were cultured for 24 hr, 5g/L MTT solution (20mL) was
added, then dimethyl sulfoxide was used for vibration and dissolve-
ment. Optical density of each hole was detected by using enzyme-
linked immunosorbent assay to analyze different concentrations of
HCY and Rb1 on the proliferation of human mammary stems cells.
Western blot was used to examine the protein expression of the cell
inﬂammatory factors, tumor necrosis factor(TNF)-a, interleukin(IL)-6,
macrohpage chemoattractant protein(MCP)-1, and intercellular adhe-
sion molecule(ICAM)-1, ELISA was used to detect the contents of the
cell inﬂammatory factors.
RESULTS HCY of different doses inhibited the viability of HUVECs
dose-dependently, the inhibition rates of HCY were 0.0990.079,
0.2390.046, 0.6370.007, and 0.5530.029 respectively (all P<0.01);
the growth rates of HCY-induced HUVECs treatment by Rb1 of the
concentrations of 10, 20, 40, and 60mmol/L were 0.6820.312,
0.7100.040, 0.8550.130, 0.7840.031 respectively, higher than
that of the control group(all P<0.01). Western blotting and ELISA
showed that homocysteine signiﬁcantly increased the expression of
TNF-a, IL-6, MCP-1 and ICAM-1, which are 0.710.15, 0.890.32,
0.800.27, 0.54012 respectively, higher than that of 0 hour
(all P<0.01). However, the expression levels of TNF-a, IL-6, MCP-1 and
ICAM-1 of the 0.50mmol/L HCY-induced HUVECs treatment by Rb1
(20mmol/L) were 0.240.04, 0.150.03, 0.130.04, 0.220.06
respectively, not signiﬁcantly different from those at the of 0 hour
(all P>0.01).
CONCLUSIONS Rb1 inhibits homocysteine-induced endothelial
impairment and inﬂammatory response, the deﬁnit mechanism of
which is expecting advanced study.
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OBJECTIVES Lipid metabolism disorders and inﬂammation response
play important roles in the pathogenesis of coronary heart disease
(CHD). Danqi Pill (DQP) is prescribed routinely in the treatment of
CHD. DQP has both anti-inﬂammatory and lipid-lowering effects.
However, its pharmacological mechanisms are not yet fully under-
stood. To provide insights into the pharmacological mechanisms of
DQP, we investigated the effects of DQP on PPARa, which regulates
lipid metabolism, and inﬂammatory factors involved in CHD.
METHODS 120 male Sprague-Dawley rats were randomly divided
into sham-operated, model group, positive drug-treated group and
DQP group. From the day after left anterior descending coronary
artery ligation operation, drugs were administered to rats intra-
gastrically for 28 consecutive days. Contents of plasma lipids were
evaluated by biochemical examination. Expressions of PPARa, key
molecules in lipid uptake-transportation-metabolism pathway
(including ApoA1, FABP and CPT1A) and key proteins in inﬂamma-
tion pathway (PLA2, COX2, NF-kB and STAT3) were examined by
western blot.
RESULTS Results showed that plasma levels of TG, LDL and VLDL
increased, whereas HDL decreased in model group, indicating that
plasma lipid metabolism was deregulated. In lipid uptake-trans-
portation pathway, protein levels of Apolipoprotein A1(ApoA1)
decreased by 12.6% and fatty acid binding protein (FABP) decreased
by 10.0% in model group. Expression of carnitine palmitoyl trans-
ferase 1A (CPT1A), which is the key enzyme in lipid utilization, was
down-regulated by 28.4%. In PLA-COXs pathway, expressions of PLA2
and COX2 increased by 47.5% and 92.5%, respectively in model group.
Expressions of NF-kB and STAT3 were also up-regulated by 35.8% and
113.9% respectively, indicating that inﬂammatory pathway was acti-
vated. PPARa level decreased by 24.3%. In DQP-treated group, lipid
disorders were regulated and the indicators returned towards normal
levels. Compared to model group, expression of ApoA1 was up-regu-
lated by 59.5% and FABP increased by 29.0% in DQP group. Expres-
sion of CPT1A was up-regulated by 54.9%. DQP also inhibited
PLA-COXs inﬂammatory pathway. Compared to model group, ex-
pressions of PLA2 and COX2 were down-regulated by 25.1% and
24.8%, respectively. STAT3 expression showed no statistic difference.
However, NF-kB level was down-regulated signiﬁcantly by 56.2%,
indicating that the anti-inﬂammatory effect of DQP is probably
mediated by NF-kB. Expression of PPARa in DQP group also increased
signiﬁcantly by 141.3% compared with model group, demonstrating
that DQP is an effective agonist of PPARa.
